Tagala, Severina .

HRN: 11-87-29  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
CEFTRIAXONE 1G (VIAL)
06/11/2025
06/18/2025
IV
2 Gram
OD
CAP MR
Waiting Final Action 
06/11/2025
AZITHROMYCIN 500MG TABLET (TAB)
06/11/2025
06/16/2025
PO
500 Mg
OD
CAP MR
Waiting Final Action 
06/14/2025
CO-AMOXICLAV 625MG (TAB)
06/14/2025
06/17/2025
PO
625 Mg/tab
TID
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: